<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">32822</article-id><article-id pub-id-type="doi">10.26442/terarkh201890253-58</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Editorial article</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Передовая статья</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Ultrasound examination with contrast in the diagnosis of inflammatory bowel disease. The results of the pilot study</article-title><trans-title-group xml:lang="ru"><trans-title>Ультразвуковое исследование с контрастированием в диагностике воспалительных заболеваний кишечника. Результаты пилотного исследования</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Fomin</surname><given-names>V V</given-names></name><name xml:lang="ru"><surname>Фомин</surname><given-names>Виктор Викторович</given-names></name></name-alternatives><bio xml:lang="ru"><p>член-корр. РАН, д.м.н., проф., проректор по лечебной работе, зав. каф. факультетской терапии №1 лечебного факультета</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ternovoy</surname><given-names>S K</given-names></name><name xml:lang="ru"><surname>Терновой</surname><given-names>Сергей Константинович</given-names></name></name-alternatives><bio xml:lang="ru"><p>академик РАН, д.м.н., проф., зав. каф. лучевой диагностики и лучевой терапии лечебного факультета</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Makhov</surname><given-names>V M</given-names></name><name xml:lang="ru"><surname>Махов</surname><given-names>Валерий Михайлович</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., проф. каф. факультетской терапии №1 лечебного факультета</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Isaykina</surname><given-names>M A</given-names></name><name xml:lang="ru"><surname>Исайкина</surname><given-names>Мария Алексеевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант каф. факультетской терапии №1 лечебного факультета</p></bio><email>manon_17@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Dzhenzhera</surname><given-names>N A</given-names></name><name xml:lang="ru"><surname>Дженжера</surname><given-names>Надежда Александровна</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., зав. отд-нием ультразвуковой диагностики Университетской клинической больницы №1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Turko</surname><given-names>T V</given-names></name><name xml:lang="ru"><surname>Турко</surname><given-names>Татьяна Васильевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., врач гастроэнтерологического отд-ния №2 Университетской клинической больницы</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ugryumova</surname><given-names>L N</given-names></name><name xml:lang="ru"><surname>Угрюмова</surname><given-names>Лидия Николаевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., зав. гастроэнтерологическим отде-нием №2 Университетской клинической больницы №1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Babenko</surname><given-names>O V</given-names></name><name xml:lang="ru"><surname>Бабенко</surname><given-names>Олег Васильевич</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., доц., гл. врач Университетской клинической больницы №1</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I. M. Sechenov First Moscow state medical University, Ministry of Health of Russia (Sechenovskiy University)</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский университет)</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-02-15" publication-format="electronic"><day>15</day><month>02</month><year>2018</year></pub-date><volume>90</volume><issue>2</issue><issue-title xml:lang="en">VOL 90, NO2 (2018)</issue-title><issue-title xml:lang="ru">ТОМ 90, №2 (2018)</issue-title><fpage>53</fpage><lpage>58</lpage><history><date date-type="received" iso-8601-date="2020-04-11"><day>11</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/32822">https://ter-arkhiv.ru/0040-3660/article/view/32822</self-uri><abstract xml:lang="en"><p>Aim. Assessment of diagnostic significance of informativeness and security of ultrasonography with contrast enhancement drug SonoVue in the diagnosis of Crohn's disease (CD) and ulcerative colitis (UC). Materials and methods. The pilot conducted a prospective study which involved 15 patients with inflammatory bowel disease (IBD). All patients gave written consent to participate in the study and processing of personal data. The study included adult patients with an established diagnosis of UC and CD, with proven clinical activity of the disease. Activity was evaluated based on clinical and laboratory data on the scale of best (CDAI &gt;150) for patients with CD and on a scale of Trulove-Witts (2-3 stage) and the Mayo index (DAI) for patients with UC. All the patients underwent colonoscopy with biopsy, ultrasound examination of abdominal cavity organs with the study of the vascularization of the intestinal wall (color Doppler, power Doppler, contrast study). Results. The use of contrast showed additional features in the instrumental evaluation of activity of inflammatory process, identification of complications and assessment of prognosis. Conclusion. The results of ultrasound of the bowel with contrast can be used to assess the activity and stage of disease in patients with UC or CD.</p></abstract><trans-abstract xml:lang="ru"><p>Цель исследования. Оценка диагностической значимости, информативности и безопасности ультразвукового исследования (УЗИ) с контрастным усилением препаратом Соновью (SonoVue) в диагностике болезни Крона (БК) и язвенного колита (ЯК). Материалы и методы. Проведено пилотное проспективное исследование, в котором приняли участие 15 пациентов с воспалительными заболеваниями кишечника (ВЗК). Все пациенты дали письменное согласие на участие в исследовании и обработку персональных данных. В исследование включали взрослых пациентов с установленным диагнозом ЯК и БК, с доказанной клинической активностью заболевания. Активность оценивалась на основании клинико-лабораторных данных по шкале Беста (CDAI &gt;150) для пациентов с БК и по шкале Trulove-Witts (2-3-я стадия) и индексу Мейо (DAI) для пациентов с ЯК. Всем больным проведены колоноскопия с биопсией, УЗИ органов брюшной полости с исследованием васкуляризации стенки кишечника (цветной допплер, энергетический допплер, контрастное исследование). Результаты. Применение контрастирования продемонстрировало дополнительные возможности в инструментальной оценке активности воспалительного процесса, в выявлении осложнений и оценке прогноза заболевания. Заключение. Результаты УЗИ кишечника с контрастированием могут использоваться для оценки активности и стадии болезни у пациентов с БК и ЯК.</p></trans-abstract><kwd-group xml:lang="en"><kwd>inflammatory bowel disease</kwd><kwd>Crohn's disease</kwd><kwd>ulcerative colitis</kwd><kwd>ultrasound with contrast</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>воспалительные заболевания кишечника</kwd><kwd>болезнь Крона</kwd><kwd>язвенный колит</kwd><kwd>УЗИ с контрастированием</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Белоусова Е.А. Язвенный колит и болезнь Крона. Тверь: Триада; 2002. 128 с.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Халиф И.Л., Лоранская И.Д. Воспалительные заболевания кишечника (неспецифический язвенный колит и болезнь Крона): клиника, диагностика, лечение. Москва: Миклош; 2004. 88 с.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>D’Incà R, Caccaro R. Measuring disease activity in Crohn’s disease: what is currently available to the clinician. Clin Exp Gastroenterol 2014;7:151-61. doi: 10.2147/CEG.S41413</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Cellier C, Sahmoud T, Froguel E, et al. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileoco lonic Crohn’s disease: a prospective multicentre study of 121 cases. Gut. 1994;35:231-5.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Ansari A, Soon S.Y, Saunders B.P, Sanderson J.D. A prospective study of the technical feasibility of ileoscopy at colonoscopy. Scand J Gastroenterol. 2003;38:1184-6.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Vilela E.G, Torres H.O.D.G, Martins F.P, Ferrari M.D, Andrade M.M, Da Cunha A.S. Evaluation of inflammatory activity in Crohn’s disease and ulcerative colitis. World J Gastroenterol. 2012;18:872-81. doi: 10.3748/ wjg.v18.i9.872.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Van de Bruaene C, De Looze D, Hindryckx P. Small bowel capsule endoscopy: where are we after almost 15 years of use? World J Gastrointest Endosc. 2015;7:13-36. doi: 10.4253/wjge.v7.i1.13</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Dambha F, Tanner J, Carroll N. Diagnostic imaging in Crohn’s disease: what is the new gold standard? Best Pract Res Clin Gastroenterol. 2014;28:421-36. doi: 10.1016/j.bpg.2014.04.010</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Sinha R, Verma R, Verma S, Rajesh A. MR enterography of Crohn disease. Part 1. Rationale, technique, and pitfalls. AJR Am J Roentgenol. 2011;197:76-9. doi: 10.2214/AJR.10.7253</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Israeli E, Ying S, Henderson B, Mottola J, Strome T, Bernstein C.N. The impact of abdominal computed tomography in a tertiary referral centre emergency department on the management of patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38:513-21. doi: 10.1111/apt.12410</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Cipriano L.E, Levesque B.G, Zaric G.S, Loftus E.V. Jr., Sandborn W.J. Cost - effectiveness of imaging strategies to reduce radiation - induced cancer risk in Crohn's disease. Inflamm Bowel Dis. 2012;18:1240-8. doi: 10.1002/ibd.21862</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Peloquin J.M, Pardi D.S, Sandborn W.J, Fletcher J.G, Mc Collough C.H, Schueler B.A, et al. Diagnostic ionizing radiation exposure in a population - based cohort of patients with inflammatory bowel disease. Am J Gastroenterol. 2008;103:2015-22. doi: 10.1111/j.1572-0241.2008. 01920</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Sheth R.A, Gee M.S. The role of imaging in inflammatory bowel disease evaluation. In: Karoui S, ed. Inflammatory bowel disease: advances in pathogenesis and management. Rijeka, Croatia: InTech; 2012. P. 137-50.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Masselli G. MR imaging of the small bowel. Radiology. 2012;264:333-48. doi: 10.1148/radiol.12111658</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Panes J, Bouhnik Y, Reinisch W, et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence - based consensus guidelines. J Crohns Colitis. 2013;7:556-85. doi: 10.1016/j.crohns.2013.02.020</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Panes J, Bouzas R, Chaparro M, Garcia-Sanchez V, Gisbert J.P, Martinez de Guerenu B, Mendoza J.L, Paredes J.M, Quiroga S, Ripolles T, Rimola J. Systematic review: The use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther. 2011;34:125-45. doi: 10.1111/j.1365-2036. m2011.04710.x</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Sasaki T, Kunisaki R, Kinoshita H, et al. Use of color Doppler ultrasonography for evaluating vascularity of small intestinal lesions in Crohn’s disease: correlation with endoscopic and surgical macroscopic findings. Scand J Gastroenterol. 2014;49:295-301. doi: 10.3109/ 00365521.2013.871744</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Horsthuis K, Bipat S, Bennink R, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta - analysis of prospective studies. Radiology. 2008;247:64-79. doi: 10.1148/radiol.2471070611</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Xuelei M, Yanyan Li, Hongyuan Jia, Jing Zhang, Guoping Wang, Xiaoxiao Liu, Yanlin Song. Contrast - enhanced ultrasound in the diagnosis of patiens suspected of having active Crohns disease: meta - analysis. Ultrasound Med Biol. 2015;41:659-68. doi: 10.1016/j.ultrasmedbio.2014.09.013</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Taylor S, Mallett S, Bhatnagar G, et al. METRIC (MR enterography or ultrasound in Crohn’s disease): a study protocol for a multicentre, non - randomised, single - arm, prospective comparison study of magnetic resonance enterography and small bowel ultrasound compared to a reference standard in those. BMC Gastroenterol. 2014;14:142. doi: 10.1186/ 1471-230X-14-142</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Parente F, Greco S, Molteni M, et al. Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical loca - tion within the bowel. Aliment Pharmacol Ther. 2003;18:1009-16.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Bodily K, Fletcher J, Solem C, et al. Crohn disease: mural attenuation and thickness at contrast - enhanced CT enterography - correlation with endoscopic and histologic findings of inflammation. Radiology. 2006;238:505-16.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Esteban J, Maldonado M, Sanchiz V, Minguez M, Benages A. Activity of Crohn’s disease assessed by colour Doppler ultrasound analysis of the affected loops. Eur Radiol. 2001;11:1423-8.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Spalinger J, Patriquin H, Miron M.C, et al. Doppler US in patients with Crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology. 2000;217:787-91.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Medellin-Kowalewski A, Wilkens R, Wilson A, Ruan J, Wilson S.R. Quantitative Contrast-Enhanced Ultrasound Parameters in Crohn Disease: Their Role in Disease Activity Determination With Ultrasound. AJR Am J Roentgenol. 2016 Jan;206(1):64-73. doi: 10.2214/ AJR. 15.14506</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Fraquelli M, Colli A, Casazza G, et al. Role of US in detection of Crohn disease: meta - analysis. Radiology. 2005;236:95-101.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Miao Y, Koh D.M, Amin Z, et al. Ultrasound and magnetic resonance imaging assessment of active bowel segments in Crohn’s disease. Clin Radiol. 2002;57:913-8.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Rigazio C, Ercole E, Laudi C, et al. Abdominal bowel ultrasound can predict the risk of surgery in Crohn’s disease: proposal of an ultrasonographic score. Scand J Gastroenterol. 2009;44:585-93.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Danese S, Sans M, de la Motte C, et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology. 2006;130:2060-73.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Romanini L, Passamonti M, Navarria M, et al. Quantitative analysis of contrast - enhanced ultra - sonography of the bowel wall can predict disease activity in inflammatory bowel disease. Eur J Radiol. 2014; 83:1317-23. doi: 10.1016/j.ejrad.2014.05.012.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Ripollés T, Martínez-Pérez M.J, Blanc E, et al. Contrast - enhanced ultrasound (CEUS) in Crohn’s disease: technique, image interpretation and clinical applications. Insights Imaging. 2011;2:639-52.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Greis C. Quantitative evaluation of microvascular blood flow by contrast - enhanced ultrasound (CEUS). Clin Hemorheol Microcirc. 2011; 49:137-49.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Wilkens R, Pournazari P, Wilson S. CEUS of the bowel in inflammatory bowel disease. 2nd ed. London, UK: International Medical Publishers; 2013. P. 222-9.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Ripollés T, Martínez M.J, Paredes J.M, Blanc E, Flors L, Delgado F. Crohn disease: correlation of findings at contrast - enhanced US with severity at endoscopy. Radiology. 2009;253:241-8.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Ripollés T, Rausell N, Paredes J.M, Grau E, Martínez M.J, Vizuete J. Effectiveness of contrast - enhanced ultrasound for characterisation of intestinal inflammation in Crohn’s disease: a comparison with surgical histopathology analysis. J Crohns Colitis. 2013;7:120-8. doi: 10.1016/ j.crohns.2012.03.002</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Serra C, Menozzi G, Labate A.M, Giangregorio F, Gionchetti P, Beltrami M, Robotti D, Fornari F, Cammarota T. Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn's disease patients using a low - mechanical index real - time scanning technique with a second generation ultrasound contrast agent. Eur J Radiol. 2007 Apr;62(1):114-21.</mixed-citation></ref></ref-list></back></article>
